Built to Deliver Extraordinary Care to Billions of Consumers Every Day

旨在每天为全球数十亿消费者提供卓越的关怀服务

Unites Leading Portfolios, Including 10 Iconic Billion-Dollar Brands, Across Highly Complementary Categories and Geographies

整合领先的产品组合，涵盖10个标志性的十亿美元级品牌，横跨高度互补的品类与地域市场

Leverages Kimberly-Clark's Powering Care Growth Engine and Proven Operating Model

依托金佰利公司的“关爱驱动增长”引擎及经验证的运营模式

to Drive Value Creation

以驱动价值创造

Kimberly-Clark Reiterates Anticipated Run-Rate Synergies of $2.1 Billion, with Value Capture Plan and Pipeline Already Charted

金佰利公司重申预期年化协同效应达21亿美元，价值捕获计划及项目储备已明确规划

DALLAS

达拉斯

,

，

Nov. 2, 2026

2026年11月2日

/PRNewswire/ -- Kimberly-Clark Corporation ('Kimberly-Clark' or 'the Company') (NASDAQ:

/美通社/ -- 金佰利公司（“金佰利”或“该公司”）（纳斯达克股票代码：

KMB

九龙巴士

), a core S&P 500 component, today announced that it has completed its acquisition of Kenvue. The combination creates the preeminent global consumer health and wellness leader, uniting leading portfolios, including 10 billion-dollar brands, to deliver extraordinary care for billions of people across every stage of life..

），作为标普500指数的核心成分股，今日宣布已完成对Kenvue的收购。此次合并造就了全球领先的消费者健康与福祉企业，整合了包括10个十亿美元级品牌在内的领先品牌组合，旨在为处于人生各个阶段的数十亿人提供卓越的健康关怀。

'Today marks a defining moment in Kimberly-Clark's 154-year history as we welcome Kenvue and hit the ground running as one company,' said Mike Hsu, Chairman and Chief Executive Officer of Kimberly-Clark. 'I am deeply grateful to our Kimberly-Clark and Kenvue teams around the world for enabling this next step.

“今天标志着金佰利154年历史上的一个决定性时刻，我们欢迎Kenvue加入，并立即以一家公司的身份全力开展工作，”金佰利董事长兼首席执行官Mike Hsu表示。“我深深感谢全球的金佰利和Kenvue团队，使这一步骤得以实现。

We share a rich heritage: pioneering entire categories and forming deep, lifelong bonds with consumers around the world as we help generations of people take care of themselves and their loved ones, every day. Now, at a moment when the need for better care is undeniable and growing, we have an urgent opportunity to be there for more people, in more places and across evolving unmet needs.

我们共享着丰厚的遗产：开创全新品类，并与全球消费者建立深厚而持久的终身纽带，助力代代人群每日呵护自身及所爱之人。当下，人们对更优质照护的需求日益增长且不容置疑，这为我们带来了紧迫的机遇，让我们能够在更多地区、面向更多人群，并针对不断演变的未满足需求，提供应有的支持与陪伴。

With Kenvue, Kimberly-Clark is equipped to combine deep consumer insight, groundbreaking science and innovation, brand-building expertise and strong commercial execution to lead the future of consumer health.'.

凭借Kenvue，金佰利公司具备了将深入的消费者洞察、突破性的科学与创新、品牌建设专长以及强大的商业执行能力相结合的实力，从而引领消费者健康领域的未来。

Hsu continued, 'Our focus now is to move with speed and purpose to unlock the full potential of this combination. I am confident that our shared commitment to care and strong execution will enable us to deliver generational value for consumers, customers and shareholders.'

徐继续表示：“我们当前的重点是迅速而有针对性地行动，以充分释放此次合并的全部潜力。我相信，我们对关怀理念的坚定承诺以及强大的执行力，将使我们能够为消费者、客户和股东创造代际价值。”

Extraordinary Starts Today

非凡始于今日

Uniting leading, trusted and iconic brands to create the preeminent global consumer health and wellness leader.

联合领先、值得信赖且具标志性的品牌，打造全球首屈一指的消费者健康与福祉领导者。

The company's combined portfolio of leading personal care and consumer health brands includes 10 billion-dollar brands: Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's Baby, Kotex and Scott.

该公司旗下领先的个人护理和消费者健康品牌组合中，包含10个价值十亿美元的品牌：好奇（Huggies）、李施德林（Listerine）、科顿妮尔（Cottonelle）、露得清（Neutrogena）、得伴（Depend）、泰诺（Tylenol）、舒洁（Kleenex）、强生婴儿（Johnson's Baby）、高洁丝（Kotex）和斯科特（Scott）。

Leading attractive categories at the intersection of fast-moving consumer goods and healthcare.

引领快速消费品与医疗保健交汇领域的高吸引力品类。

Healthcare has become more personal, proactive, and essential as consumers are underserved by traditional healthcare systems, leaving them to assemble their own solutions. The company leads in many of the industry's largest, most attractive categories, including baby care, women's health and active aging.

由于传统医疗保健体系未能充分满足消费者需求，迫使他们自行拼凑解决方案，医疗保健已变得更具个性化、更主动且更为重要。该公司在婴儿护理、女性健康和积极老龄化等多个行业规模最大、最具吸引力的细分领域中处于领先地位。

As global spending on health and wellness reaches more than $500 billion annually, Kimberly-Clark is well positioned to capture growing demand for science-backed, high-quality and high-performance solutions across everyday needs..

随着全球在健康与保健领域的年度支出超过5,000亿美元，金佰利公司凭借其在日常需求领域提供科学背书、高品质且高性能解决方案的能力，处于有利地位以把握不断增长的市场需求。

Elevating the standard of care through three strategic pillars: Better Care, More Hands and Smarter Health.

通过三大战略支柱提升护理标准：更优护理、更多人力、更智慧健康。

The company's combined brands will serve consumers more comprehensively throughout their health and care journeys, raising the bar on everyday care. Kimberly-Clark will extend its reach to more people in more places, across evolving needs.

公司旗下的联合品牌将为消费者在健康与护理全程提供更全面的服务，提升日常护理的标准。金佰利将扩大覆盖范围，触达更多地区的人群，满足其不断变化的需求。

Deploying Kimberly-Clark's proven growth engine with best-in-class execution and management.

部署金佰利公司久经验证的增长引擎，并以一流的执行力和管理加以推进。

Kimberly-Clark's Powering Care growth engine will enhance the performance and potential of Kenvue's portfolio by accelerating innovation, deepening brand love and improving commercial execution. Kimberly-Clark has appointed a purpose-built leadership team with the right experience, capabilities and technical expertise to drive a focus on winning in the company's local markets..

金佰利公司的“赋能关爱”增长引擎将通过加速创新、深化品牌喜爱度以及提升商业执行能力，来增强科维优产品组合的表现和潜力。金佰利已组建一支专门打造的领导团队，该团队具备合适的经验、能力和专业技术，以推动公司在各地市场赢得竞争优势。

Delivering a differentiated financial framework supported by substantial synergies.

提供由显著协同效应支撑的差异化财务框架。

Kimberly-Clark reaffirms anticipated run-rate synergies of approximately $2.1 billion, consisting of approximately $1.9 billion in cost synergies, captured in the first three years following close, and approximately $500 million in incremental profit from revenue synergies, partially offset by reinvestment of approximately $300 million, captured within four years post-close.

金佰利公司重申，预计年化协同效应约为21亿美元，其中包括在交易完成后的前三年内实现的约19亿美元成本协同效应，以及在交易完成后四年内实现的约5亿美元收入协同效应带来的增量利润，部分被约300万美元的再投资所抵消。

The company has substantially built its pipeline of cost and revenue initiatives as part of a robust integration plan..

作为稳健整合计划的一部分，该公司已大幅充实其成本与营收举措的项目储备。

Segments and Leadership for Best-in-Class Execution

业务板块与领导力，助力实现卓越执行

As previously announced, Kimberly-Clark will operate with four business segments:

正如先前宣布的那样，金佰利将以四个业务部门运营：

North America, a business generating approximately $18.0 billion

北美地区，一个创造约180亿美元收入的业务板块

1

1

in sales annually;

年销售额；

Asia Pacific Focus Markets, which will include Greater China, Australia / New Zealand, South Korea, and Indonesia, generating approximately $4.3 billion

亚太区重点市场，包括大中华区、澳大利亚/新西兰、韩国和印度尼西亚，营收约为43亿美元

1

1

in annual sales;

在年销售额方面；

Europe, Middle East, and Africa (EMEA), with approximately $5.0 billion

欧洲、中东和非洲（EMEA），约50亿美元

1

1

in annual sales; and

在年销售额中；以及

Enterprise Markets, which will include Latin America (including Brazil), India, Southeast Asia markets, and Japan, generating approximately $4.3 billion

企业市场，涵盖拉丁美洲（包括巴西）、印度、东南亚市场和日本，营收约为43亿美元

1

1

in annual sales.

年销售额。

Kimberly-Clark's executive leadership biographies are available on the company's

金佰利公司高管领导的个人简介可在该公司

website

网站

.

。

Board and Governance

董事会与治理

As previously announced, three members of the Kenvue Board of Directors have joined the Kimberly-Clark Board of Directors, which now comprises 13 directors:

如此前公告，三名科恩休（Kenvue）董事会成员已加入金佰利（Kimberly-Clark）董事会，该董事会现由13名董事组成：

Mike Hsu, Chairman and CEO

苏姿丰，董事长兼首席执行官

Sherilyn S. McCoy, Lead Independent Director

谢丽林·S·麦考伊，首席独立董事

Richard E. Allison, Jr.

小理查德·E·艾利森

Sylvia M. Burwell

西尔维娅·M·伯韦尔

John W. Culver

约翰·W·卡尔弗

Deeptha Khanna

迪普塔·坎纳

S. Todd Maclin

S. 托德·麦克林

Deirdre A. Mahlan

迪尔德丽·A·马兰

Larry Merlo

拉里·梅洛

Kirk Perry

柯克·佩里

Joseph Romanelli

约瑟夫·罗马内利

Dunia A. Shive

杜尼娅·A·希夫

Mark T. Smucker

马克·T·斯穆克

In connection with the close of the transaction, Mae C. Jemison, Christa S. Quarles and Jaime A. Ramirez have stepped down from the Kimberly-Clark Board effective immediately.

随着交易的完成，梅·C·杰米森、克里斯塔·S·夸尔斯和海梅·A·拉米雷斯已立即辞去金佰利公司董事会职务。

Transaction Details

交易详情

With the completion of the transaction, Kenvue shareholders will receive $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each Kenvue share held. Shares of Kenvue's common stock, which traded on the New York Stock Exchange under the symbol 'KVUE,' ceased trading as of the market opening on November 2, 2026..

随着交易完成，Kenvue 股东每持有一股 Kenvue 股票，将获得 3.50 美元现金和 0.14625 股金佰利普通股。Kenvue 普通股此前在纽约证券交易所上市，股票代码为“KVUE”，已于 2026 年 11 月 2 日市场开盘时停止交易。

About Kimberly-Clark

关于金佰利

Kimberly-Clark (NASDAQ:

金佰利（纳斯达克股票代码：

KMB

九巴

) is the preeminent global health and wellness leader, built to deliver extraordinary care. Our portfolio of iconic personal care and consumer health brands, including Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's Baby, Kotex and Scott, serves consumers across every stage of life in more than 175 countries.

）是全球健康与福祉领域的卓越领导者，致力于提供非凡的护理服务。我们拥有包括好奇（Huggies）、李施德林（Listerine）、可舒雅（Cottonelle）、露得清（Neutrogena）、得伴（Depend）、泰诺（Tylenol）、舒洁（Kleenex）、强生婴儿（Johnson's Baby）、高洁丝（Kotex）和斯科特（Scott）在内的一系列标志性个人护理和消费者健康品牌，为遍布全球175多个国家的消费者提供贯穿人生各个阶段的服务。

We combine consumer-led innovation, leading brand-building and commercial capabilities, and a fast and agile operating model to raise the standard of care for billions of people around the world. We are committed to using sustainable practices designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come.

我们将消费者驱动的创新、领先的品牌建设与商业能力，以及快速敏捷的运营模式相结合，旨在提升全球数十亿人口的护理标准。我们致力于采用可持续实践，以支持地球健康、构建强大社区，并确保我们的业务在未来数十年持续繁荣发展。

The KMB stock is a large cap growth and value stock and core S&P 500 equity held by more than 400 Exchange Traded Funds. Kimberly-Clark is considered a Dividend Aristocrat, having paid a dividend for 92 consecutive years and increasing its dividend in each of the past 54 consecutive years. To keep up with the latest news and learn more about the company's more than 150-year history, visit the .

金佰利（KMB）股票是一只大盘成长与价值股，也是标普500指数的核心成分股，被400多只交易所交易基金（ETF）持有。金佰利公司被视为“股息贵族”，已连续92年支付股息，并在过去连续54年中每年提高股息。如需了解最新新闻并更深入地了解该公司超过150年的历史，请访问。

Kimberly-Clark website

金佰利网站

.

。

Cautionary Statement Regarding Forward-Looking Statements

关于前瞻性陈述的警示性声明

Certain matters contained in this press release concerning our plans and expectations regarding the integration of Kenvue, including anticipated synergies, cost savings, integration costs and the timing thereof, our business outlook and anticipated transactions of Kimberly-Clark, including dividends, share repurchases and pension contributions, constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 and are based upon management's expectations and beliefs concerning future events impacting Kimberly-Clark.

本新闻稿中包含的某些有关我们对Kenvue整合的计划与预期的事项，包括预期的协同效应、成本节约、整合成本及其时间安排，以及我们对金佰利公司的业务展望和预期交易（包括股息、股票回购和养老金缴款），均构成1995年《私人证券诉讼改革法案》意义上的“前瞻性陈述”，并基于管理层对影响金佰利公司未来事件的预期和信念。

There can be no assurance that these future events will occur as anticipated or that our results will be as estimated. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them. Some of these forward-looking statements can be identified by words like 'anticipate,' 'approximately,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'forecast,' 'intend,' 'may,' 'outlook,' 'plan,' 'potential,' 'possible,' 'predict,' 'project,' 'target,' 'seek,' 'should,' 'will,' or 'would,' the negative of these words, other terms of similar meaning or the use of future dates..

无法保证这些未来事件会按预期发生，也无法保证我们的结果会与估算一致。前瞻性陈述仅反映其作出之日的情况，我们不承担公开更新这些陈述的义务。部分前瞻性陈述可通过“预期”、“大约”、“相信”、“继续”、“可能”、“估计”、“期望”、“预测”、“打算”、“或许”、“展望”、“计划”、“潜在”、“有可能”、“预判”、“规划”、“目标”、“寻求”、“应该”、“将”或“将会”等词语、这些词语的否定形式、其他具有类似含义的术语或使用未来日期来识别。

The assumptions used as a basis for the forward-looking statements include many estimates that, among other things, depend on the successful integration of Kenvue and the achievement of future cost savings and projected volume increases. In addition, many factors outside our control could affect the realization of these estimates.

作为前瞻性陈述基础的假设包括许多估计，这些估计除其他外，取决于Kenvue的成功整合、未来成本节约的实现以及预期销量的增长。此外，许多我们无法控制的因素可能会影响这些估计的实现。

These include risks and uncertainties related to the Kenvue acquisition and the integration of Kenvue's business, including the risk that the anticipated benefits, synergies and cost savings of the Kenvue acquisition may not be realized when expected or at all, the risk that integration costs may be higher than expected, the risk of loss of key employees, customers, suppliers or other business counterparties, the risk of disruption to our or Kenvue's operations, the risk of litigation related to the Kenvue acquisition, our substantially increased indebtedness following the Kenvue acquisition and our ability to reduce our indebtedness, maintain our credit ratings and refinance indebtedness on favorable terms, legal proceedings and governmental investigations, indemnification obligations to Johnson & Johnson ('J&J'), and the sufficiency of, and J&J's ability to satisfy, its indemnification obligations, risks related to the IFP Transaction, including risks related to the incurrence of significant transaction and separation costs, adverse market reactions, regulatory or legal challenges, and operational disruptions, our ability to realize the anticipated benefits of the 2024 Transformation Initiative (including risks related to disruptions to our business or operations or related to any delays in implementation), war in Ukraine (including the related responses of consumers, customers, and suppliers and sanctions issued by the U.S., the European Un.

这些因素包括与收购肯维尤（Kenvue）及其业务整合相关的风险和不确定性，其中包括：预期从收购肯维尤中获得的收益、协同效应和成本节约可能无法按预期实现或完全无法实现的风险；整合成本可能高于预期的风险；关键员工、客户、供应商或其他商业合作伙伴流失的风险；我们或肯维尤运营中断的风险；与收购肯维尤相关的诉讼风险；收购肯维尤后我们债务大幅增加的现状，以及我们减少债务、维持信用评级并以有利条件为债务再融资的能力；法律诉讼和政府调查；对强生公司（“J&J”）的赔偿义务，以及强生公司履行其赔偿义务的能力和充分性；与IFP交易相关的风险，包括产生重大交易和分拆成本的风险、不利的市场反应、监管或法律挑战以及运营中断；我们实现2024年转型计划预期收益的能力（包括与我们的业务或运营中断或实施延迟相关的风险）；乌克兰战争（包括消费者、客户和供应商的相关反应，以及美国、欧盟发布的制裁措施。

The factors described under Item 1A, 'Risk Factors' in our Annual Report on Form 10-K for the year ended December 31, 2025, as updated by our Quarterly Reports on Form 10-Q and our other SEC filings, among others, could cause our future results to differ from those expressed in any forward-looking statements made by us or on our behalf.

我们在截至2025年12月31日的年度10-K报表中“风险因素”（第1A项）下描述的因素，以及通过我们的季度10-Q报表和其他美国证券交易委员会（SEC）文件更新的因素，可能导致我们未来的实际结果与我们或代表我们作出的任何前瞻性陈述中表达的结果存在差异。

Other factors not presently known to us or that we presently consider immaterial could also affect our business operations and financial results..

其他目前我们尚不知晓或我们认为不重要的因素，也可能影响我们的业务运营和财务业绩。

Important Note about Combined Financial Information

关于合并财务信息的重要提示

The financial information for the combined businesses of Kimberly-Clark and Kenvue is based on management's estimates and assumptions and has not been prepared in conformance with the applicable requirements of Regulation S-X relating to pro forma financial information, and the required pro forma adjustments under Regulation S-X have not been applied and are not reflected therein.

金佰利与Kenvue合并业务的财务信息基于管理层的估计和假设编制，并未遵循S-X法规中关于备考财务信息的相关规定，因此未应用也未反映S-X法规所要求的备考调整。

This information is provided for illustrative purposes only and should not be considered in isolation from, or as a substitute for, the historical financial statements of Kimberly-Clark or Kenvue. Various factors could cause actual future results to differ materially from those currently estimated by management, including, but not limited to, the risk factors discussed in Kimberly-Clark's most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and future filings with the SEC..

本信息仅供说明之用，不应孤立地看待，也不应作为金佰利（Kimberly-Clark）或科颜氏（Kenvue）历史财务报表的替代品。多种因素可能导致实际未来结果与管理层当前的估计存在重大差异，包括但不限于金佰利最新提交的10-K表年度报告中讨论的风险因素，该等风险因素已由其10-Q表季度报告及未来向美国证券交易委员会（SEC）提交的文件更新。

[KMB-F] [KMB-C]

[KMB-F] [KMB-C]

Contacts

联系人

Investor Relations:

投资者关系：

Christopher Jakubik, CFA

克里斯托弗·雅库比克，特许金融分析师

[email protected]

[email protected]

Media Relations:

媒体关系：

Kyrsten Aspegren

克斯滕·阿斯佩格伦

[email protected]

[email protected]

1

1

Represents the combined net sales of Kimberly-Clark and Kenvue for fiscal year 2025, as reported in each company's Annual Report on Form 10-K, recast to reflect the estimated impact of the new proposed segment structure. See 'Important Note about Combined Financial Information.'

代表金佰利和Kenvue在2025财年的合并净销售额，数据源自各公司在10-K表格年度报告中披露的信息，并经过重述以反映新提议的分部结构预计产生的影响。参见“关于合并财务信息的重要说明”。

SOURCE Kimberly-Clark Corporation

来源：金佰利公司